S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
These are the Top 4 Stocks for Buybacks in 2024
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
These are the Top 4 Stocks for Buybacks in 2024
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
These are the Top 4 Stocks for Buybacks in 2024
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
These are the Top 4 Stocks for Buybacks in 2024

Allakos (ALLK) Stock Forecast & Price Target

$1.06
+0.01 (+0.95%)
(As of 04/17/2024 ET)

Allakos Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 5 Analyst Ratings

Analysts' Consensus Price Target

$1.83
72.96% Upside
High Forecast$3.00
Average Forecast$1.83
Low Forecast$1.00
TypeCurrent Forecast
4/19/23 to 4/18/24
1 Month Ago
3/20/23 to 3/19/24
3 Months Ago
1/19/23 to 1/19/24
1 Year Ago
4/19/22 to 4/19/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$1.83$1.83$9.21$14.75
Predicted Upside72.96% Upside57.59% Upside140.68% Upside139.16% Upside
Get Allakos Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ALLK and its competitors with MarketBeat's FREE daily newsletter.

ALLK Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALLK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Allakos Stock vs. The Competition

TypeAllakosMedical CompaniesS&P 500
Consensus Rating Score
2.20
2.68
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside72.96% Upside934.49% Upside12.27% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/17/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Outperform ➝ Market Outperform$10.00 ➝ $3.00+170.27%
1/17/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$1.50 ➝ $1.00-15.97%
1/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$6.00 ➝ $1.50+26.05%
1/16/2024Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Kim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral
12/18/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Lugo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 09:19 AM ET.

ALLK Price Target - Frequently Asked Questions

What is Allakos's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for Allakos stock is Hold based on the current 1 sell rating, 2 hold ratings and 2 buy ratings for ALLK. The average twelve-month price prediction for Allakos is $1.83 with a high price target of $3.00 and a low price target of $1.00. Learn more on ALLK's analyst rating history.

Do Wall Street analysts like Allakos more than its competitors?

Analysts like Allakos less than other Medical companies. The consensus rating for Allakos is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how ALLK compares to other companies.

Does Allakos's stock price have much upside?

According to analysts, Allakos's stock has a predicted upside of 57.59% based on their 12-month stock forecasts.


Stock Ratings Reports and Tools

This page (NASDAQ:ALLK) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners